Corrigendum to “Amiodarone Induces Cell Proliferation and Myofibroblast Differentiation via ERK1/2 and p38 MAPK Signaling in Fibroblasts” (Biomedicine & Amp; Pharmacotherapy (2019) 115, (S0753332218378752), (10.1016/j.biopha.2019.108889))

The authors regret the order and address of corresponding authors of the original article were given incorrectly. The correct order of all authors is as follows: Jie Weng1, Mengyun Tu1, Peng Wang, Xiaoming Zhou, Chuanyi Wang, Xinlong Wan, Zhiliang Zhou, Liang Wang, Xiaoqun Zheng, Junjian Li, Chan Chen**, Zhiyi Wang**, Zhibin Wang*. The correct corresponding author at: Institute of Bioscaffold Transplantation and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, China. This reflects the fact that Zhibin Wang was the main contributing corresponding author to the original article. The authors would like to apologise for any inconvenience caused